It could be the source of a treatment for the common cold, too. Axerion of new haven, connecticut, through its eli. George maynard president and chief scientific officer. The cover image representing article number 1900161 by jonathan f lovell and co. Axerion therapeutics is focused on the research and development of therapeutics for neurological diseases and injuries. Based at yale university in new haven, the team found that mice with ab plaques but no prpc showed no cognitive impairment.
Branford biotech expanding to bigger space after raising. Axerion therapeutics is a biotech company focused on developing innovative. Cara tannenbaum, who was appointed by nemer to help lead the cancovid. How to save outlook email as pdf 3 methods available. Aspyrian therapeutics is a clinical stage oncology company developing novel precisiontargeted therapies based on the photoimmunotherapy technology pit platform. He and his team spent a halfdozen years investigating the bodys inability to repair itself following injury to the central nervous system, and developing a drug to block growth inhibitors. Translational neuropharmacology consulting, llc, potomac, md, usa. New havenbased biotech company advances innovative treatments for neurological injuries and diseases. Pdf cr845 difelikefalin, a kappa receptors agonist in phase iii.
Degenerative cervical myelopathy, spinal cord injury. Guidelines for the management of degenerative cervical myelopathy and acute spinal cord injury. The awards were made pursuant to the nasdaq inducement grant exception as a component of the new hires employment. Addex therapeutics is a clinicalstage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the. We are rethinking the future of medicine with people at the center of the experience. See who you know at axerion therapeutics, leverage your professional network, and get hired. Traumatic spinal cord injurys secondary injury cascade the secondary injury cascade is a series of changes that begin within just a few hours after the sci and may continue months past the initial injury. The project involves developing a compound nogo receptor decoy to rewire nerve cells that promote the recovery of neurological function.
In 2010, strittmatter formed a company called axerion therapeutics with the yale office of cooperative research. Abstract axonal growth and neurological recovery after traumatic spinal cord injury sci is limited by the presence of inhibitory proteins in myelin, several of which act via the ngr1 protein in n. Wanstall to chief financial officer and treasurer, effective immediately. Development of nogo receptor decoy for the treatment of spinal cord injury, george maynard, phd, axerion therapeutics, inc. The lots will have a staggered closing time with 2 closing every minute in numerical order. Therapeutics definition of therapeutics by the free. About us celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Alrn, the clinicalstage leader in the field of stabilized, cellpermeating peptides, announced today the promotion of richard j. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. After more than doubling, esperion therapeutics, inc. Branford is cts quiet bioscience startup hub hartford. On the day the auction is set to close, each lot will clearly countdown the time left until closing. Learn how to convert outlook e mails to pdf with adobe acrobat in windows 1087.
Intarcia therapeutics rethinking the future of medicine. View george maynards profile on linkedin, the worlds largest professional community. Ct invests in yale alzheimers therapy hartford business. Gaba and schizophrenia targets and emerging therapies. Jane pritchett henderson has been appointed vp of business development for ista. Axerion of new haven, connecticut, through its eli whitney fund. The production of human ngr10fc by expression in a stable chos cell line at axerion therapeutics has been described. Fimbrion therapeautics pioneers antivirulence solutions to treat utis. Intravitreal delivery of human ngrfc decoy protein regenerates.
Renetxs erika smith fights the good fight against spinal. Clinical practice guidelines for the management of degenerative cervical myelopathy and acute traumatic spinal cord injury. With technology licensed from the university of tuebingen, ovesco endoscopy has set out to address one of the biggest challenges of notes procedures. Intarcia therapeutics is dedicated to redesigning the treatment of chronic disease. Pit utilizes antibody conjugates that accumulate at the tumor after systemic infusion and can be activated with light to induce rapid, specific, and robust tumor destruction. He has focused his academic and business career on the application of developmental biology to. Regulation of axonal regeneration by the level of function. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new wiley online library. The company is also using chitin as the basis for programs in novel allergy and asthma therapies, vaccine adjuvants, and nutritional products. Hyperion therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases. Fimbrion and gsk to develop novel antibacterial therapy for urinary tract infections.
The current knowledge of the role of ldha in the brain and its potential as a therapeutic target for brain tumors will also be highlighted. Alzheimers disease ad is a devastating neurodegenerative disorder, afflicting more than onethird of people over the age of 85. Using proprietary assays, cognition therapeutics inc. Ptc therapeutics reports inducement grants under nasdaq. Intravitreal delivery of human ngrfc decoy protein. Biotechcareers is funded in part by the national science foundation. Chitin may be the second most common molecule on earth. Axerion therapeutics october 2010 january 2014 3 years 4.
This months profile group, alzheimers startups face a discovery and clinical crossroads, features profiles of alzprotect, axerion therapeutics, cognition therapeutics and galantos pharma. This drug is currently developed by cara therapeutics. The expression vector encodes aa residues 10 of human ngr1 with the cys266ala and cys309ala substitutions fused to the fc domain of human igg1, as described for rat protein previously. Contact siteone therapeutics, headquartered in bozeman, montana with a research team in south san francisco, california, is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Human ngr10fc was expressed in a stable chos cell line at axerion therapeutics. Alexion is a global biopharmaceutical company focused on developing lifechanging therapies for people living with rare disorders. Siteone therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Cara, a biopharmaceutical company focused on developing. Stock protein solutions at 10 mgml were stable for greater than 1 year at. Axerion was established in new haven to develop and commercialize intellectual property licensed from dr.
While many therapies for ad are in latestage clinical testing, rational drug design based on distinct signaling pathways in this disorder is only now emerging. The work we do is guided by people living with rare and devastating diseases. Ptct today announced that on october 25, 2019 it approved nonstatutory stock options to purchase an aggregate of 339,875 shares of its common stock to 27 new employees. Human ngrfc decoy protein via lumbar intrathecal bolus. A branford diagnostics biotech that developed a handheld device to detect organisms that cause infectious diseases is expanding its footprint in the shoreline town with a planned move to a new 16,200squarefoot facility. Facebook view on facebook linkedin view on linkedin contact email kim. You are cordially invited to attend the 2018 annual meeting of stockholders of axsome therapeutics, inc. Ovesco has developed a clipping system that imitates the mechanics the geometry and force pattern of a surgical suture, but with advantages. Living with a rare disease isnt just about the treatment, its also about channeling uncertainty and fear into something. The regulation and function of lactate dehydrogenase a. New haven, ct, usa i may 1, 2012 i axerion therapeutics, inc. It forms a new principle to treat chronic or postoperative pain by a peripheral acting.